Miranda, André Miguel
Bravo, Francisca Vaz
Chan, Robin B.
Sousa, Nuno
Di Paolo, Gilbert
Oliveira, Tiago Gil http://orcid.org/0000-0003-0509-0562
Article History
Received: 12 November 2018
Accepted: 2 April 2019
First Online: 26 April 2019
Conflict of interest
: G.D.P. is a full-time employee of Denali Therapeutics Inc. G.D.P. and T.G.O. are inventors on the patent number WO2010138869A1 entitled “Modulation of phospholipase D for the treatment of neurodegenerative disorders”. R.B.C., G.D.P., and T.G.O. are inventors on the patent number US20120302604A1 entitled “Modulation of phospholipase D for the treatment of the acute and chronic effects of ethanol”.